Podcast: Has Russia’s COVID Vaccine Gotten Lost In Politics?

{
  "authors": [
    "Alexander Gabuev",
    "Polina Ivanova",
    "Henry Foy"
  ],
  "type": "commentary",
  "centerAffiliationAll": "",
  "centers": [
    "Carnegie Endowment for International Peace",
    "Carnegie Russia Eurasia Center"
  ],
  "collections": [
    "Coronavirus"
  ],
  "englishNewsletterAll": "",
  "nonEnglishNewsletterAll": "",
  "primaryCenter": "Carnegie Endowment for International Peace",
  "programAffiliation": "",
  "programs": [],
  "projects": [],
  "regions": [],
  "topics": []
}

Commentary

Podcast: Has Russia’s COVID Vaccine Gotten Lost In Politics?

This episode looks at the domestic and international reception of Russia’s Sputnik V vaccine.

By Alexander Gabuev, Polina Ivanova, Henry Foy

Published on Mar 30, 2021

Is Russia’s Sputnik V coronavirus vaccine as successful as the Kremlin claims? Are political considerations really preventing it from getting approval in Western countries? Why is the vaccination rate so low in Russia, and why didn’t Putin get vaccinated sooner? Podcast host Alex Gabuev is joined by Henry Foy, Moscow bureau chief of the Financial Times; and Polina Ivanova, a special correspondent for Reuters in Moscow.

Listen or download: SoundCloud | Subscribe: iTunes, Google Podcasts, Google Play, Spotify, RSS

Carnegie does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.

More Work from Carnegie Endowment for International Peace

Commentary
Russia’s Response to Its Spiraling COVID-19 Crisis Is Too Little, Too Late
As Russia weathers a fourth surge of COVID-19 cases, the country’s management of the public health challenge has yet to improve. What factors led the country here, and what does this mean for the Putin regime and the Russian people going forward?
Paul Stronski
Paper
Civil Society and the Global Pandemic: Building Back Different?
Civil society groups are simultaneously responding to the pandemic’s direct impacts and looking to a post-pandemic future. Many economic, political, and geostrategic challenges are shaping their thinking and their strategies.
Carnegie Civic Research Network
Commentary
Is There Any COVID-19 Vaccine Production in Africa?
Efforts are being made to ramp up production of COVID-19 vaccines in Africa to address the continent’s low rate of vaccination. As of September 2021, there are at least twelve COVID-19 production facilities set up or in the pipeline across six African countries.
Zainab Usman, Juliette Ovadia
Commentary
How the Global Vaccine Divide Is Fueling Indonesia’s Coronavirus Catastrophe
As Indonesia reels under staggering rates of COVID-19, an ambitious mass inoculation drive offers hope. But limited access to effective vaccines is trapping the Asian giant in an impossible choice between saving lives and livelihoods.
Sana Jaffrey
Commentary
Russia’s Vaccine Diplomacy Is Mostly Smoke and Mirrors
Russian scientists rolled out the country’s COVID-19 vaccine last summer, beating Western vaccine producers to the finish line. But scarce data, broken promises, and corruption have led the vaccine to lose its luster.
Grace Kier, Paul Stronski

More Work from Carnegie Endowment for International Peace

Commentary

Russia’s Response to Its Spiraling COVID-19 Crisis Is Too Little, Too Late

As Russia weathers a fourth surge of COVID-19 cases, the country’s management of the public health challenge has yet to improve. What factors led the country here, and what does this mean for the Putin regime and the Russian people going forward?

Paul Stronski

Paper

Civil Society and the Global Pandemic: Building Back Different?

Civil society groups are simultaneously responding to the pandemic’s direct impacts and looking to a post-pandemic future. Many economic, political, and geostrategic challenges are shaping their thinking and their strategies.

Carnegie Civic Research Network

Commentary

Is There Any COVID-19 Vaccine Production in Africa?

Efforts are being made to ramp up production of COVID-19 vaccines in Africa to address the continent’s low rate of vaccination. As of September 2021, there are at least twelve COVID-19 production facilities set up or in the pipeline across six African countries.

Zainab Usman, Juliette Ovadia

Commentary

How the Global Vaccine Divide Is Fueling Indonesia’s Coronavirus Catastrophe

As Indonesia reels under staggering rates of COVID-19, an ambitious mass inoculation drive offers hope. But limited access to effective vaccines is trapping the Asian giant in an impossible choice between saving lives and livelihoods.

Sana Jaffrey

Commentary

Russia’s Vaccine Diplomacy Is Mostly Smoke and Mirrors

Russian scientists rolled out the country’s COVID-19 vaccine last summer, beating Western vaccine producers to the finish line. But scarce data, broken promises, and corruption have led the vaccine to lose its luster.

Grace Kier, Paul Stronski